Depressive symptoms and mortality in men: results from the Multiple Risk Factor Intervention Trial.
作者： Brooks B. Gump , Karen A. Matthews , Lynn E. Eberly , Yue-fang Chang
DOI: 10.1161/01.STR.0000149626.50127.D0
关键词:
摘要: Background and Purpose— Depression may be a risk factor for cardiovascular disease (CVD) mortality. We evaluated long-term mortality associated with depressive symptoms measured at middle age among men high coronary heart (CHD). Methods— 12 866 without definite evidence of CHD study entry but who had above average based on blood pressure, cholesterol levels, and/or cigarette smoking were recruited into the Multiple Risk Factor Intervention Trial (MRFIT). Survivors end trial followed-up an additional 18 years. Men completed Center Epidemiologic Studies (CES-D) scale near (n=11 216) used in prospective analysis post-trial all-cause cause-specific during 18-year follow-up after CES-D assessment. Results— Greater significantly higher cause-speci...
syr.edu参考文章(25)
Robert C. Benfari, The multiple risk factor intervention trial (MRFIT). Preventive Medicine. ,vol. 10, pp. 426- 442 ,(1981) , 10.1016/0091-7435(81)90059-1
Bruce S. Jonas, Michael E. Mussolino, Symptoms of depression as a prospective risk factor for stroke. Psychosomatic Medicine. ,vol. 62, pp. 463- 471 ,(2000) , 10.1097/00006842-200007000-00001
Sylvia Wassertheil-Smoller, William B Applegate, Kenneth Berge, Chee Jen Chang, Barry R Davis, Richard Grimm, John Kostis, Sara Pressel, Eleanor Schron, Change in Depression as a Precursor of Cardiovascular Events Archives of Internal Medicine. ,vol. 156, pp. 553- 561 ,(1996) , 10.1001/ARCHINTE.1996.00440050111012
G Rose, P McCartney, D D Reid, Self-administration of a questionnaire on chest pain and intermittent claudication. Journal of Epidemiology & Community Health. ,vol. 31, pp. 42- 48 ,(1977) , 10.1136/JECH.31.1.42
Wei Jiang, Ranga R.K. Krishnan, Christopher M. O??Connor, Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs. ,vol. 16, pp. 111- 127 ,(2002) , 10.2165/00023210-200216020-00004
Csaba M. Banki, Lajos Karmacsi, Garth Bissette, Charles B. Nemeroff, CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse European Neuropsychopharmacology. ,vol. 2, pp. 107- 113 ,(1992) , 10.1016/0924-977X(92)90019-5
Christoph Herrmann, Sigrid Brand-Driehorst, Britta Kaminsky, Eric Leibing, Hermann Staats, Ulrich Ruger, Diagnostic Groups and Depressed Mood as Predictors of 22-Month Mortality in Medical Inpatients Psychosomatic Medicine. ,vol. 60, pp. 570- 577 ,(1998) , 10.1097/00006842-199809000-00011
Sylvia Wassertheil-Smoller, Sally Shumaker, Judith Ockene, Greg A. Talavera, Philip Greenland, Barbara Cochrane, John Robbins, Aaron Aragaki, Jacqueline Dunbar-Jacob, Depression and Cardiovascular Sequelae in Postmenopausal Women Archives of Internal Medicine. ,vol. 164, pp. 289- 298 ,(2004) , 10.1001/ARCHINTE.164.3.289
Lawson R. Wulsin, George E. Vaillant, Victoria E. Wells, A Systematic Review of the Mortality of Depression Psychosomatic Medicine. ,vol. 61, pp. 6- 17 ,(1999) , 10.1097/00006842-199901000-00003